View in EDS HTML Full Text PDF Full Text

Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.

Saved in:
Bibliographic Details
Title: Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.
Authors: Rudofsky G; Praxis für Endokrinologie, Diabetes und Adipositas, Olten, Solothurn, Switzerland. Gottfried.rudofsky@hin.ch., Menzen M; Gemeinschaftskrankenhaus, Bonn, Germany., Potier L; Université Paris Cité, AP-HP, Bichat Hospital, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Paris, France., Catarig AM; Novo Nordisk A/S, Søborg, Denmark., Clark A; Novo Nordisk A/S, Søborg, Denmark., Priyadarshini P; Novo Nordisk GBS, Bengaluru, India., Abreu C; Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Source: Advances in therapy [Adv Ther] 2025 Feb; Vol. 42 (2), pp. 788-800. Date of Electronic Publication: 2024 Dec 05.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39636564
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rudofsky+G%22">Rudofsky G</searchLink>; Praxis für Endokrinologie, Diabetes und Adipositas, Olten, Solothurn, Switzerland. Gottfried.rudofsky@hin.ch.<br /><searchLink fieldCode="AU" term="%22Menzen+M%22">Menzen M</searchLink>; Gemeinschaftskrankenhaus, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Potier+L%22">Potier L</searchLink>; Université Paris Cité, AP-HP, Bichat Hospital, INSERM U1151, CNRS UMR8253, Institut Necker Enfants Malades, Paris, France.<br /><searchLink fieldCode="AU" term="%22Catarig+AM%22">Catarig AM</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Clark+A%22">Clark A</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Priyadarshini+P%22">Priyadarshini P</searchLink>; Novo Nordisk GBS, Bengaluru, India.<br /><searchLink fieldCode="AU" term="%22Abreu+C%22">Abreu C</searchLink>; Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Feb; Vol. 42 (2), pp. 788-800. <i>Date of Electronic Publication: </i>2024 Dec 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39636564
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-024-03000-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 788
    Titles:
      – TitleFull: Glucagon-Like Peptide-1 Receptor Agonist-Experienced Adults with Type 2 Diabetes Switching to Once-Weekly Semaglutide in a Real-World Setting: SURE Program Post Hoc Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rudofsky G
      – PersonEntity:
          Name:
            NameFull: Menzen M
      – PersonEntity:
          Name:
            NameFull: Potier L
      – PersonEntity:
          Name:
            NameFull: Catarig AM
      – PersonEntity:
          Name:
            NameFull: Clark A
      – PersonEntity:
          Name:
            NameFull: Priyadarshini P
      – PersonEntity:
          Name:
            NameFull: Abreu C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1